BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 16122678)

  • 1. Treatment of Clostridium difficile-associated disease: old therapies and new strategies.
    Aslam S; Hamill RJ; Musher DM
    Lancet Infect Dis; 2005 Sep; 5(9):549-57. PubMed ID: 16122678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Past, present, and future therapies for Clostridium difficile-associated disease.
    Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
    Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent Clostridium difficile infection: causality and therapeutic approaches.
    Johnson S
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S33-6. PubMed ID: 19303567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment strategies for C. difficile associated diarrhea.
    Stepan C; Surawicz CM
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center.
    Lupse M; Flonta M; Cioara A; Filipescu I; Todor N
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):397-403. PubMed ID: 24369321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile and the disease it causes.
    Norén T
    Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future treatment modalities for Clostridium difficile-associated disease.
    Halsey J
    Am J Health Syst Pharm; 2008 Apr; 65(8):705-15. PubMed ID: 18387898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.
    DuPont HL; Garey K; Caeiro JP; Jiang ZD
    Curr Opin Infect Dis; 2008 Oct; 21(5):500-7. PubMed ID: 18725800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection.
    Musgrave CR; Bookstaver PB; Sutton SS; Miller AD
    Int J Infect Dis; 2011 Jul; 15(7):e438-48. PubMed ID: 21596604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP; Surawicz CM
    Am J Gastroenterol; 2007 Dec; 102(12):2789-92. PubMed ID: 18042108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.
    Anton PM; O'Brien M; Kokkotou E; Eisenstein B; Michaelis A; Rothstein D; Paraschos S; Kelly CP; Pothoulakis C
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3975-9. PubMed ID: 15388461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
    Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile: an update for the primary care clinician.
    Salkind AR
    South Med J; 2010 Sep; 103(9):896-902. PubMed ID: 20697321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters.
    Kokkotou E; Moss AC; Michos A; Espinoza D; Cloud JW; Mustafa N; O'Brien M; Pothoulakis C; Kelly CP
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1121-6. PubMed ID: 18195066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The approach to recurrent infections with Clostridium difficile].
    Paz Z; Altman A
    Harefuah; 2008 Nov; 147(11):864-5, 942. PubMed ID: 19264004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    Johnson S
    J Infect; 2009 Jun; 58(6):403-10. PubMed ID: 19394704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
    Bouza E; Muñoz P; Alonso R
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():57-64. PubMed ID: 15997485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.